KMDA: Wutah pendapatan triwulanan Kamada Ltd.

Kamada Ltd. (KMDA) - logo korporat

Stable cash flow from government contracts and global sales of biologics supports the R&D activity of Kamada Ltd. (KMDA). Quarterly revenue changes visualize the pace of fund generation, where 10.80 serves as the current parameter value. Growth is driven by contracts with Takeda and expansion in the US, although business success relies on plasma availability and the efficacy of new treatments for genetic pathologies.

KMDA Tambahing pendapatan triwulanan Kamada Corp (04.07.2022 - 20.11.2026)

Ringkesan rincian data analitis Kamada Ltd (KMDA)

- rega saham lan target rega konsensus:
Analisis kabeh metrik perusahaan:Kamada Pharma (KMDA)
Produk sing diprodhuksi Kamada

Kamada Ltd. manages a complex plasma processing infrastructure in Israel and logistics in the US. This metric measures the percentage change in sales volume for the current quarter relative to the previous one, identifying short-term demand trends. For the investor, this serves as an indicator of operational efficiency and the stability of biopharmaceutical supplies. By analyzing the QoQ revenue growth rate, one can determine the market cycle phase and the risk of cooling demand.

Pesaing Kamada Ltd. (KMDA)

Vertex Pharmaceuticals - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan ALNY (Alnylam Pharmaceuticals)|INSM: Wutah pendapatan triwulanan|United Therapeutics Corp (UTHR) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal BioMarin Pharma|BBIO: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan BGM|Wutah dodolan triwulanan Cogent Biosciences COGT|Wutah pendapatan triwulanan XERS (xerispharma.com)|Wutah pendapatan triwulanan Keros Therapeutics Inc KROS|Arcturus Therapeutics Inc - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Eton Pharmaceuticals|FULC (Fulcrum Corp) - Wutah dodolan triwulanan|ABEO (Abeona Therapeutics, Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan triwulanan PLRX|Wutah pendapatan kuartal marang kuartal APLT (Applied Therapeutics)|Rein Therapeutics Inc - Wutah dodolan triwulanan|Gelteq Limited (GELS) - Tingkat wutah pendapatan sajrone kuartal|aytubio.com - Wutah pendapatan triwulanan|chemomab.com (CMMB) - Wutah dodolan triwulanan|SRXH: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal PLRZ (Polyrizon Ltd.)|Wutah dodolan triwulanan AEZS|CYTH: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal inozyme.com (INZY)|Wutah pendapatan triwulanan Reneo Pharmaceuticals Inc. (RPHM)|Wutah pendapatan triwulanan CSCI (Aeterna Zentaris)